Curbing the hepatitis C virus epidemic in Pakistan: the impact of scaling up treatment and prevention for achieving elimination

International Journal of Epidemiology
Aaron G LimPeter Vickerman

Abstract

The World Health Organization (WHO) has developed a global health strategy to eliminate viral hepatitis. We project the treatment and prevention requirements to achieve the WHO HCV elimination target of reducing HCV incidence by 80% and HCV-related mortality by 65% by 2030 in Pakistan, which has the second largest HCV burden worldwide. We developed an HCV transmission model for Pakistan, and calibrated it to epidemiological data from a national survey (2007), surveys among people who inject drugs (PWID), and blood donor data. Current treatment coverage data came from expert opinion and published reports. The model projected the HCV burden, including incidence, prevalence and deaths through 2030, and estimated the impact of varying prevention and direct-acting antiviral (DAA) treatment interventions necessary for achieving the WHO HCV elimination targets. With no further treatment (currently ∼150 000 treated annually) during 2016-30, chronic HCV prevalence will increase from 3.9% to 5.1%, estimated annual incident infections will increase from 700 000 to 1 100 000, and 1 400 000 HCV-associated deaths will occur. To reach the WHO HCV elimination targets by 2030, 880 000 annual DAA treatments are required if prevention is not scal...Continue Reading

References

Sep 18, 2007·Lancet·Sania Nishtar
Jun 20, 2008·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Hla-Hla TheinMurray D Krahn
Dec 5, 2009·World Journal of Gastroenterology : WJG·Yasir WaheedIshtiaq Qadri
Mar 20, 2010·Journal of Cancer Education : the Official Journal of the American Association for Cancer Education·Mukesh Kumar KrishananiAli Khan Khuwaja
Apr 5, 2013·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Natasha K MartinMatthew Hickman
Aug 3, 2014·Journal of Hepatology·Erin GowerHomie Razavi
Dec 3, 2014·Journal of Hepatology·Rachel H Westbrook, Geoffrey Dusheiko
Jan 24, 2015·Antiviral Research·Camilla S Graham, Tracy Swan
Jun 9, 2016·Liver International : Official Journal of the International Association for the Study of the Liver·Amr KandeelMaha Talaat
Oct 21, 2016·MMWR. Morbidity and Mortality Weekly Report·Lia GvinjiliaFrancisco Averhoff
Apr 14, 2017·The Lancet. Gastroenterology & Hepatology·UNKNOWN Polaris Observatory HCV Collaborators
Jul 27, 2017·Vaccine· World Health Organization
Nov 17, 2017·The American Journal of Tropical Medicine and Hygiene·Adam TrickeyPeter Vickerman

❮ Previous
Next ❯

Citations

May 11, 2019·JAMA Network Open·Jagpreet ChhatwalFasiha Kanwal
Sep 1, 2019·Journal of Internal Medicine·J V LazarusJ F Dillon
Aug 29, 2019·BMC Health Services Research·Tomoyuki HayashiBenedetta Allegranzi
Aug 11, 2020·Journal of Gastroenterology and Hepatology·Antoine ChaillonNatasha K Martin
Sep 16, 2019·BMC Infectious Diseases·Sarwat MahmudLaith J Abu-Raddad
Mar 13, 2019·Hepatology Communications·Aaron G LimPeter Vickerman
Oct 22, 2019·Lancet·C Wendy SpearmanMark Sonderup
Mar 14, 2020·The International Journal on Drug Policy·Lara K MarquezNatasha K Martin
Apr 3, 2021·Journal of Viral Hepatitis·Blessing DzingiraiNyashadzaishe Mafirakureva
Apr 16, 2021·The Lancet. Gastroenterology & Hepatology·Matthew J AkiyamaUNKNOWN International Network on Health and Hepatitis in Substance Users–Prisons Network
Dec 23, 2019·The Lancet Global Health·Josephine G WalkerPeter Vickerman

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.